1. Home
  2. ONTF vs CCCC Comparison

ONTF vs CCCC Comparison

Compare ONTF & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON24 Inc.

ONTF

ON24 Inc.

HOLD

Current Price

$7.96

Market Cap

212.8M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.92

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONTF
CCCC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.8M
240.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ONTF
CCCC
Price
$7.96
$1.92
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$6.70
$7.25
AVG Volume (30 Days)
316.0K
1.9M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$141,348,000.00
$30,108,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$1.09
52 Week High
$8.10
$4.26

Technical Indicators

Market Signals
Indicator
ONTF
CCCC
Relative Strength Index (RSI) 82.34 34.02
Support Level $5.72 $1.93
Resistance Level $8.10 $2.13
Average True Range (ATR) 0.14 0.13
MACD 0.20 -0.03
Stochastic Oscillator 94.19 2.53

Price Performance

Historical Comparison
ONTF
CCCC

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: